Track topics on Twitter Track topics that are important to you
(NYU Tandon School of Engineering) Clinicians today have a huge arsenal of drugs at their disposal for treating cancers. But many chemotherapeutic agents pose stubborn challenges: they cause serious side effects, some cancers develop resistance, and many chemotherapies demonstrate low bio-availability. A potential solution lies in the synergistic combination of a chemotherapeutic drug with engineered genetic material. New hybrid materials developed at NYU Tandon combine a lipid 'container' for transfection and a protein capsule to deliver a chemical one-two punch.NEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...